As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. David Bronstein is a pediatric infectious disease specialist at Kaiser Permanente in the Antelope Valley. He is vice area research chair for Antelope Valley on the Southern California Permanente Medical Group’s Regional Research Committee. He is an elected member of the Southern California Permanente Medical Group Board of Directors and the assistant area medical director, overseeing Pediatrics, Mental Health, Care Experience, and Equity, Inclusion and Diversity, Vaccination Programs, and ...
Over the years, clinical trials have led to amazing advances in treatment—even cures—for devastating illnesses. William Towner, MD, FACP, FIDSA, regional physician director for clinical trials, describes how trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more. (2:15)
Emergency department use was common for adolescent and young adult cancer survivors within 5 years of a cancer diagnosis, and differences in use were associated with social and demographic factors and cancer type, according to a new Kaiser Permanente study. The American Cancer Society reports that more young people are being diagnosed with cancer. Understanding ...
A nurse and health services researcher, Huong Q. Nguyen, PhD, RN, focuses her research on the care of older adults with chronic and serious illnesses. She is the co-lead of the Care Improvement Research Team and interim director of the Division of Health Services Research & Implementation for the Department of Research & Evaluation. She ...
Michael J. Fassett, MD, came to work at Kaiser Permanente in 2000. Since then, his dedication to his patients through research has grown. He’s published more than 50 research papers in peer-reviewed journals. Now, as the regional physician-in-charge for Maternal-Fetal Medicine and the area research chair for the West Los Angeles and Kern County service ...
A Kaiser Permanente study shows the Pfizer-BioNTech BNT162b2 BA.4/5 bivalent mRNA vaccine helped protect against a range of COVID symptoms and was effective against the COVID XBB strain sublineages. The most substantial benefit of the bivalent vaccine booster was keeping people out of the hospital and keeping people from becoming critically ill. The study was ...
A study of more than 1 million Kaiser Permanente members ages 19 and younger found that rates of both type 1 and type 2 diabetes increased among children during the COVID-19 pandemic, particularly for those ages 10 and older, male children, and children in specific racial and ethnic groups. The study was published September 21, ...
Kids and diabetes, improving outbreak predictions, one doctor’s journey into research, and a profile of a neuroscientist trying to improve care for patients with MS. This and more in IMPACT, the newsletter of the Kaiser Permanente Southern California Department of Research & Evaluation.
Investigators with the Division of Epidemiologic Research apply rigorous research methods to address important health questions that have the potential to change clinical practice and health care delivery. The division’s research portfolio spans the care continuum, from etiology and prevention to survivorship and quality of life.
Division investigators have expertise in traditional epidemiologic studies, post-marketing safety and effectiveness studies, and outcomes research. Current research areas include cancer, cardiovascular disease, COVID-19, diabetes, infectious disease, molecular epidemiology, orthopedics and bone health, perinatal health, pharmacoepidemiology, and vaccines.